I’m 35 years into this, and here’s the truth I wish someone had said to me early on, clearly and without the brochure version.
Parkinson’s is not a dopamine deficiency.
That’s the headline because it’s easy to explain and easier to treat. Dopamine loss gives you the visible stuff—tremor, stiffness, slowness, the moments where your body just doesn’t cooperate. That part is real. That part is measurable. That part gets attention.
But it’s not the whole disease.
Because dopamine doesn’t explain why your blood pressure drops when you stand and spikes when you lie down. It doesn’t explain why your energy disappears mid-sentence. It doesn’t explain why your gut slows to a crawl or why your heart suddenly feels like it’s doing its own thing.
That’s because Parkinson’s isn’t just affecting movement. It’s affecting regulation.
And that brings us to the part almost nobody explains well: norepinephrine.
Deep in the brainstem is the locus coeruleus, the primary source of norepinephrine in the brain. This system is responsible for keeping the body running in the background. Blood pressure, heart rate, alertness, stress response, digestion—this is the wiring that keeps everything stable without you thinking about it.
In Parkinson’s, this system degenerates. Often early. Sometimes before the classic motor symptoms even show up.
This isn’t speculation. Pathological staging work has shown involvement of the locus coeruleus and related brainstem structures in Parkinson’s progression (Braak et al., 2003). Studies of autonomic function and catecholamine systems have demonstrated loss of norepinephrine signaling and impaired regulation (Goldstein, 2003; Goldstein, 2014).
What that means in real life is simple.
Your body stops regulating cleanly.
This is what gets labeled as dysautonomia, which sounds technical but translates to something very practical: the automatic systems aren’t automatic anymore.
You see it in patterns like these.
Blood pressure that drops when you stand up, then overshoots when you’re lying down.
Fatigue that isn’t about sleep but about system failure.
Digestion that slows down without explanation.
Temperature regulation that makes no sense.
A general feeling that your internal “settings” are off.
There is strong clinical and imaging evidence supporting this. Cardiac sympathetic denervation has been demonstrated in Parkinson’s patients using MIBG imaging, showing that the heart is not receiving normal norepinephrine signaling from the nervous system (Orimo et al.). Baroreflex dysfunction and impaired autonomic responses are also well documented (Palma and Kaufmann, 2018).
This is where the brain–heart connection becomes impossible to ignore.
The heart does not operate independently. It is constantly regulated by the autonomic nervous system. Signals from the brain tell it when to speed up, slow down, constrict, or relax.
When those signals become inconsistent, the heart doesn’t get clean instructions.
So what you feel is not always a primary heart problem. Sometimes it’s a signaling problem.
That shows up as palpitations, variability in heart rate, and blood pressure swings that don’t follow a predictable pattern.
Now let’s be precise about something that matters.
Atrial Fibrillation is an electrical disorder of the heart. Parkinson’s does not directly cause atrial fibrillation.
But Parkinson’s can absolutely create a physiological environment that makes arrhythmias more likely to appear or harder to control. When the autonomic system is unstable, the balance between sympathetic and parasympathetic input to the heart is disrupted. Add in blood pressure variability, stress on the cardiovascular system, and individual susceptibility, and you have a situation where the heart is dealing with inconsistent upstream control.
So no, Parkinson’s didn’t invent AFib. But it can make the landscape more complicated.
If the story stopped at dopamine and norepinephrine, it would already be more accurate than what most people are told. But it still wouldn’t be complete.
Because Parkinson’s affects multiple neurotransmitter systems at the same time.
Dopamine handles movement and motivation. Its loss produces the motor symptoms everyone recognizes.
Norepinephrine handles regulation—blood pressure, heart rate, alertness. Its loss produces instability and fatigue.
Acetylcholine is involved in attention, memory, and aspects of motor coordination. In Parkinson’s, there is both imbalance with dopamine and degeneration of cholinergic systems, contributing to cognitive changes and attentional issues.
Serotonin regulates mood, anxiety, and sleep. Serotonergic dysfunction in Parkinson’s has been linked to depression, anxiety, and sleep disturbances that are not simply reactions to having a chronic illness.
GABA and glutamate act as the brain’s braking and acceleration systems. Dopamine loss disrupts the balance between them, leading to abnormal signaling in motor circuits. This contributes to rigidity, tremor, and, in the context of long-term levodopa therapy, dyskinesias.
What you are left with is not a single-chemical deficiency.
You are dealing with a network problem.
Movement is affected. Regulation is affected. Mood and cognition are affected. The autonomic system is affected. And through that system, the heart is indirectly affected.
This is why people with Parkinson’s often feel like their symptoms don’t line up neatly.
Because they don’t.
They are coming from different systems failing in different ways at the same time.
Now let’s talk about treatment, because this is where people either get clarity or get misled.
Therapies that stabilize dopamine, including continuous infusion approaches like Vyalev, can make a significant difference. By smoothing out dopamine delivery, they reduce motor fluctuations and lower overall system stress. Many people feel more stable, more functional, and more predictable.
That improvement is real.
But it does not mean the disease has been simplified.
Dopamine stabilization does not restore norepinephrine systems. It does not repair autonomic dysfunction. It does not rebalance all neurotransmitters. In some cases, once the motor chaos is reduced, the non-motor and autonomic symptoms become more noticeable because they are no longer being masked by constant movement fluctuations.
So you can be doing better and still have symptoms that don’t make sense if you’re only thinking in terms of dopamine.
That’s not a contradiction. That’s a more accurate picture of the disease.
The reason most people have never been given this full explanation is not because the information doesn’t exist. It’s because it doesn’t fit neatly into a simple model. Dopamine is clean, measurable, and treatable. The rest is complex, variable, and harder to address in a short clinical interaction.
So the system defaults to the simplest version.
Patients live the complicated one.
The bottom line is this.
Parkinson’s is a multi-system neurological disease. It affects dopamine, norepinephrine, acetylcholine, serotonin, and the balance of GABA and glutamate. It disrupts the autonomic nervous system that connects the brain to the heart and regulates the body’s automatic functions.
If you only understand dopamine, you understand part of the disease.
If you understand the brain–heart connection and the broader neurotransmitter involvement, the experience stops feeling random.
It starts making sense.
Citations
Braak H, Del Tredici K, Rüb U, et al. Staging of brain pathology related to sporadic Parkinson’s disease. Neurobiology of Aging. 2003.
Goldstein DS. Orthostatic hypotension as an early finding in Parkinson’s disease. Clinical Autonomic Research. 2003.
Goldstein DS. Dysautonomia in Parkinson’s disease: neurocardiological abnormalities. 2014.
Palma JA, Kaufmann H. Autonomic disorders predicting Parkinson’s disease. Parkinsonism & Related Disorders. 2018.
Orimo S, et al. Cardiac sympathetic denervation in Parkinson’s disease demonstrated by MIBG myocardial scintigraphy. Annals of Neurology.
#ParkinsonsDisease #MoreThanDopamine #BrainHeartConnection #Dysautonomia #ParkinsonsAwareness #NonMotorSymptoms #ChronicIllness #Neurology #InvisibleIllness #VoiceUnshaken
